-
Dr. Steven Grinspoon: Statin Drugs Can Be Used for Primary Prevention of Cardiovascular Diseases in HIV-Infected Individuals
With the success of highly active antiretroviral therapy (HARRT), the life expectancy of HIV-infected individuals has significantly increased in recent years. The aging problem of HIV patients has become one of the main reasons affecting the quality of life and prognosis in the post-HARRT era. From July 23-26, 2023, the 12th International AIDS Society HIV…
-
Dr. Minghua Zheng’s Team: AI-Based Digital Pathology Provides New Insights into NASH Fibrosis Reversal Induced by Lifestyle Intervention
Non-Alcoholic Steatohepatitis (NASH) is a common cause of chronic liver disease, and the degree of liver fibrosis is an important factor determining its clinical prognosis. Lifestyle intervention is the cornerstone…
-
Dr. Weiping Cai: Long-Acting Antiretroviral Drugs Usher in a New Chapter in AIDS Care
AIDS remains one of the most significant public health issues worldwide, with around 38 million people living with HIV (PLWH). In recent years, with the continuous advancement of antiretroviral therapy (ART), AIDS has gradually transformed into a manageable chronic disease. However, PLWH still face challenges like poor drug adherence and increased risk of resistance. Therefore,…
-
Challenges in HIV Management: Enhancing the Quality of Life for Elderly PLWH, Policy Interventions are Imperative
IAS current President Sharon Lewin emphasized, “The past 40 years of HIV research tells us that our HIV prevention and treatment work will be effective only when science, policy, and activism come together.” At this IAS conference, the concept of primary healthcare (PHC) for HIV, as highlighted in the World Health Organization (WHO) updated HIV…
-
Dr. Hongzhou Lu: NAD Management is Key for HIV Patients, Not Just Changing Medication
The use of highly active antiretroviral therapy (HAART) has led to effective virological control in HIV-infected individuals, significantly reducing mortality rates and transforming AIDS into a treatable and manageable chronic disease. Today, one of the main clinical challenges is how to choose more “efficient and less toxic” treatment options to improve patients’ quality of life.…
-
Dr. Wei Cao: Focus on Managing HIV Complications, Further Improving Patient Survival
The 12th International AIDS Society Conference on HIV Science (IAS 2023) was held from July 23-26, 2023, in Brisbane, Australia. As the largest open scientific conference in the global field of HIV/AIDS, it attracted the participation of experts, medical professionals, community organizations, and healthcare companies worldwide. Dr. Wei Cao from Peking Union Medical College Hospital,…
-
Dr. Yun He: The Impact of Rapid ART Initiation on HIV Outcomes
The concept of rapid initiation of antiretroviral therapy (ART) has been proposed for nearly 10 years, and many studies have confirmed the long-term benefits of rapid ART initiation. At the 12th International AIDS Society HIV Science Conference (IAS 2023), Thai scholar Sirinya Teeraananchai reported a study on the impact of rapid ART initiation on the…
-
Dr. Hui Wang: Second-line treatment choice for children with HIV infection
Currently, the choice of second-line antiretroviral therapy (ART) for children infected with HIV is extremely limited. At the12th International AIDS Society HIV Science Conference (IAS 2023), researchers announced the results of a significant clinical study, the CHAPAS-4 ( Abstract No. OALBB0503), focusing on the long-term treatment outcomes of second-line therapy in children with HIV infections.…
Connecting Medical Expertise through Media